Kynam Capital Management »

Dynavax Technologies shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Dynavax Technologies (DVAX) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Dynavax Technologies

Tip: Access up to 7 years of quarterly data

All positions including Dynavax Technologies held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dynavax Technologies by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $21M 1.5M 13.98
2023-09-30 $7.4M 500k 14.77

More positions owned by Kynam Capital Management

Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
Protagonist Therapeutics (PTGX)
ImmunoGen
Morphosys Sponsored Ads (MOR)
Cogent Biosciences (COGT)
Liquidia Corporation Com New (LQDA)
BioCryst Pharmaceuticals (BCRX)
2seventy Bio Common Stock (TSVT)
Dynavax Technologies Corp Com New (DVAX)
Wave Life Sciences SHS (WVE)
Corcept Therapeutics Incorporated Put Option (CORT)

View all positions for Kynam Capital Management

Top funds holding Dynavax Technologies

Federated Investors
Vanguard Group
Chicago Capital
Dimensional Fund Advisors
Goldman Sachs Group
Eventide Asset Management
William Blair $ Company
Kynam Capital Management
Fisher Investments
Charles Schwab Investment Management
Bank of New York Mellon
Principal Financial Group
Mizuho Markets Americas
Bank Of Montreal
Nomura Holdings

View all funds holding Dynavax Technologies